Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease

Diabetologia

Volumn 52, Issue 12, 2009, Pages 2536-2541

  Villar, E ^a,b   Polkinghorne, K R ^a,c,d   Chang, S H ^a,e,f   Chadban, S J ^a,g,h   McDonald, S P ^a,e,f  

^a Australia and New Zealand Dialysis and Transplant Registry   (Australia)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e QUEEN ELIZABETH HOSPITAL   (Australia)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ANZDATA Registry; AusDiab Study; Diabetes; End stage kidney disease; Standardised mortality ratio

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

ADULT; AGED; AUSTRALIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY CORTEX NECROSIS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY DISEASES; RENAL REPLACEMENT THERAPY;

EID: 70849096937     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1525-2     Document Type: Article

References (10)

1. AS Levey JA Beto BE Coronado, et al.. 1998 Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease Am J Kidney Dis 32 853 906 10.1016/S0272-6386(98) 70145-3 1:STN:280:DyaK1M%2Fjs1entA%3D%3D 9820460
2. E Villar L Remontet M Labeeuw R Ecochard 2007 Effects of age, sex and diabetes on excess death in end-stage renal failure J Am Soc Nephrol 18 2125 2134 10.1681/ASN.2006091048 17582163 (Pubitemid 47041078)
3. ANZDATA Registry report 2006 (2007) Australia and New Zealand Dialysis and Transplant Registry. ANZDATA Registry, Adelaide
4. Barr ELM, Magliano DJ, Zimmet PZ, the AusDiab Steering Committee, et al. (2005) The Australian Diabetes, Obesity and Lifestyle Study. Tracking the accelerating epidemic: its cause and outcome. The International Diabetes Institute, Melbourne
5. Breslow NE, Day NA (1987) Statistical methods in cancer research: volume II-the design and analysis of cohort studies (IARC scientific publications no. 82). International Agency for Research on Cancer, Lyon
6. E Villar SH Chang SP McDonald 2007 Incidences, treatments, outcomes, and gender effect on survival in end-stage renal disease patients by diabetic status in Australia and New Zealand (1991-2005) Diabetes Care 30 3070 3076 10.2337/dc07-0895 17848610 (Pubitemid 350255248)
7. A Karamé M Labeeuw P Trolliet, et al.. 2009 The impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders Nephron Clin Pract 112 268 275 10.1159/000224794
8. RN Foley AM Murray S Li, et al.. 2005 Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 J Am Soc Nephrol 16 489 495 10.1681/ASN.2004030203 15590763 (Pubitemid 41725146)
9. Australian Bureau of Statistics (2009) Deaths, Australia, 2007 (cat. no. 3302.0). Available from www.abs.gov.au/AUSSTATS/absat.nsf/Lookup/3302. 0Main+Features12007?OpenDocument, accessed 14 June 2009
10. ME Jones AJ Swerdlow 1998 Bias in the standardized mortality ratio when using the general population rates to estimate expected number of deaths Am J Epidemiol 148 1012 1017 1:STN:280:DyaK1M%2FksFeguw%3D%3D 9829874